|
1
|
Booth A, Magnuson A, Fouts J and Foster M: Adipose tissue, obesity and adipokines: Role in cancer promotion. Horm Mol Biol Clin Investig. 21:57–74. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Iyengar NM, Gucalp A, Dannenberg AJ and Hudis CA: Obesity and cancer mechanisms: Tumor microenvironment and inflammation. J Clin Oncol. 34:4270–4276. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Calle EE, Rodriguez C, Walker-Thurmond K and Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348:1625–1638. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Fuster JJ, Ouchi N, Gokce N and Walsh K: Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 118:1786–1807. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cotillard A, Poitou C, Torcivia A, Bouillot JL, Dietrich A, Klöting N, Grégoire C, Lolmede K, Blüher M and Clément K: Adipocyte size threshold matters: Link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 99:E1466–E1470. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A, Hashimoto I, Okada T, Yasuhara A, Nakatsuka A, et al: Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 102:10610–10615. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jung CH, Lee WJ, Hwang JY, Seol SM, Kim YM, Lee YL and Park JY: Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase/Akt pathway. Biochem Biophys Res Commun. 413:264–269. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fazeli MS, Dashti H, Akbarzadeh S, Assadi M, Aminian A, Keramati MR and Nabipour I: Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine. 62:81–85. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Erdogan S, Yilmaz FM, Yazici O, Yozgat A, Sezer S, Ozdemir N, Uysal S, Purnak T, Sendur MA and Ozaslan E: Inflammation and chemerin in colorectal cancer. Tumour Biol. 37:6337–6342. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kan JY, Lee YC, Lin YD, Ho WY and Moi SH: Effect of baseline characteristics and tumor burden on vaspin expression and progressive disease in operable colorectal cancer. Diagnostics (Basel). 10(801)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wong RS: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 30(87)2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E and Lothe RA: Portrait of the PI3K/AKT pathway in colorectal cancer. Biochim Biophys Acta. 1855:104–121. 2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kukla M, Mazur W, Bułdak RJ and Zwirska-Korczala K: Potential role of leptin, adiponectin and three novel adipokines - visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med. 17:1397–1410. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kukla M, Waluga M, Sawczyn T, Berdowska A, Kajor M, Boryczka G, Stygar D, Gabriel A, Zwirska-Korczala K and Hartleb M: Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy. Pol J Pathol. 63:213–220. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pazgan-Simon M, Kukla M, Zuwała-Jagiełło J, Derra A, Bator M, Menżyk T, Lekstan A, Grzebyk E and Simon K: Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC). PLoS One. 15(e0227459)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Skonieczna M, Hudy D, Hejmo T, Buldak RJ, Adamiec M and Kukla M: The adipokine vaspin reduces apoptosis in human hepatocellular carcinoma (Hep-3B) cells, associated with lower levels of NO and superoxide anion. BMC Pharmacol Toxicol. 20(58)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzinska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B and Menkiszak J: Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer. Onco Targets Ther. 11:1363–1372. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Erdogan S, Sezer S, Baser E, Gun-Eryilmaz O, Gungor T, Uysal S and Yilmaz FM: Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer. Endocr Relat Cancer. 20:669–675. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Phalitakul S, Okada M, Hara Y and Yamawaki H: Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res. 64:493–500. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jabbari S, Hedayati M, Yaghmaei P and Parivar K: Medullary thyroid carcinoma - Circulating status of vaspin and retinol binding protein-4 in Iranian patients. Asian Pac J Cancer Prev. 16:6507–6512. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ginis Z, Ucar F, Erdogan S, Ozturk G, Akyol S, Erden G, Arslan MS and Delibasi T: Serum vaspin and adiponectin levels in patients with prolactinoma. Scand J Clin Lab Invest. 76:17–24. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhu X, Jiang Y, Shan PF, Shen J, Liang QH, Cui RR, Liu Y, Liu GY, Wu SS, Lu Q, et al: Vaspin attenuates the apoptosis of human osteoblasts through ERK signaling pathway. Amino Acids. 44:961–968. 2013.PubMed/NCBI View Article : Google Scholar
|
